ML
Mario M. Leitao
Highly rated in
24
conditions
Highly rated in
24
conditions
Check Dr. Mario M. Leitao's experience treating your condition:
About Dr. Mario M. Leitao

Mario Leitao is a Gynecologic Oncologist and an Obstetrics and Gynecologist in Newark, New Jersey. Leitao has been practicing medicine for over 26 years and is highly rated in 24 conditions, according to our data. His top areas of expertise are Endometrial Cancer, Vulvar Cancer, Vaginal Cancer, Hysterectomy, and Oophorectomy. He is licensed to treat patients in New Jersey. Leitao is currently accepting new patients.

His clinical research consists of co-authoring 236 peer reviewed articles and participating in 7 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Mario M. Leitao it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Mario M. Leitao accepts the following insurance:

  •  Ambetter
Locations
30 Bergen St, Admc 12 1205, Newark, NJ 07107
Background & Education
Graduate Institution
Rutgers R W Johnson Medical School (Cam/new Bruns/pisc), 1996
Specialties
Gynecologic Oncology
Obstetrics and Gynecology
Licenses
Obstetrics & Gynecology in NJ
Hospital Affiliations
Memorial Sloan Kettering Cancer Center
Shore Medical Center
Languages Spoken
English
Spanish
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

Pilot Trial of the Robotic Uterine Manipulator
A Phase III Randomized Controlled Trial of Negative Pressure Wound Therapy in Post-Operative Incision Management
Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)
View 5 Less Clinical Trials -

236 Total Publications

Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservation.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors